In addition, TXNIP is involved in the regulation of β-cell function, cellular glucose uptake and hepatic glucose output, overall providing adverse effects on glucose homeostasis and acting as a potential therapeutic target for diabetes [54,74]. The gene discussed is TXNIP; the disease is diabetes mellitus.